Paul Gerskowitch Joins PFP Board

Profactor Pharma Ltd is pleased to announce the appointment of Dr V Paul Gerskowitch to its board. Dr Gerskowitch joins the board of Profactor Pharma Ltd as an Investor Director with extensive, board level experience in the life sciences industries.  He currently...

Press Release March 2015 – Penrose enquiry

Hope for Haemophiliacs   Despite the controversy and disappointment emerging from the final report of the Penrose Inquiry into contaminated blood, which led to infection and death of hundreds of Scots, including haemophiliacs, new hope is emerging in a small...

Series A Financing

ProFactor Pharma closed its Series A round of financing in August 2013. The funding was provided principally by members of the Business Angel Syndicate Kelvin Capital, Glasgow, and the Scottish Investment Bank Co-investment Fund. Some of the existing shareholders,...